Brind.

Neurotech company Longeviti secured a strategic capital partnership from Soleus Capital and gained a board chair appointment from Tim Scannell, who has ties to Stryker.

1 report, 1 independent Updated Aug 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Stryker Corporation

Keep exploring

The entities involved

Stryker Corporation
American medical technologies company
- Norges Bank bought a new position in Stryker Corporation shares, while Vanguard lessened its existing holding.Mon 02:09
- Medtronic is ramping up its Hugo RAS system to compete with Intuitive Surgical, while its neuroscience unit faces competitive pressure from Stryker and Globus Medical.Sun 14:58

Coverage

Newest first; wire copies grouped

Aug 8GlobeNewswireTim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital Appointment to Chair of the Board and Additional Growth Funding A